<DOC>
	<DOC>NCT00960245</DOC>
	<brief_summary>The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80 mg) tablets under fasting conditions.</brief_summary>
	<brief_title>Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Chest Pain</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nadolol</mesh_term>
	<criteria>No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Positive test results for HIV or hepatitis B or C. Treatment for drug or alcohol dependence.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>